Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,975 | 215 | 78.6% |
| Travel and Lodging | $791.40 | 1 | 20.9% |
| Education | $20.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,344 | 122 | $0 (2024) |
| Ovesco Endoscopy USA, Inc. | $791.40 | 1 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $309.21 | 33 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $251.21 | 15 | $0 (2024) |
| Medtronic, Inc. | $207.00 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $204.14 | 12 | $0 (2023) |
| Array BioPharma Inc. | $136.37 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $114.74 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $104.19 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $80.76 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $381.77 | 20 | Gilead Sciences, Inc. ($99.55) |
| 2023 | $1,167 | 25 | Ovesco Endoscopy USA, Inc. ($791.40) |
| 2022 | $727.98 | 56 | ABBVIE INC. ($297.33) |
| 2021 | $809.01 | 56 | AbbVie Inc. ($345.95) |
| 2020 | $402.48 | 42 | AbbVie Inc. ($344.80) |
| 2019 | $297.58 | 18 | Array BioPharma Inc. ($136.37) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.21 | General |
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.08 | General |
| 08/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 08/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Immunology | ||||||
| 06/01/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.43 | General |
| 04/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Neuroscience | ||||||
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.82 | General |
| 03/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology | ||||||
| 03/05/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Immunology | ||||||
| 01/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Neuroscience | ||||||
| 01/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Immunology | ||||||
| 01/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/07/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Immunology | ||||||
| 12/07/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/16/2023 | AbbVie Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 427 | 550 | $388,603 | $55,794 |
| 2022 | 22 | 527 | 609 | $482,723 | $65,040 |
| 2021 | 21 | 510 | 608 | $374,057 | $66,486 |
| 2020 | 16 | 461 | 533 | $295,981 | $55,027 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 127 | $23,601 | $7,533 | 31.9% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 20 | 23 | $27,878 | $7,397 | 26.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 45 | $23,220 | $5,948 | 25.6% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 31 | 32 | $51,552 | $5,364 | 10.4% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 15 | 17 | $14,654 | $3,792 | 25.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 40 | $10,680 | $3,627 | 34.0% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $21,504 | $2,905 | 13.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $8,775 | $2,471 | 28.2% |
| 43275 | Removal of stent from pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 11 | 11 | $11,231 | $2,429 | 21.6% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 20 | $21,520 | $2,340 | 10.9% |
| 43266 | Placement of stent in esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 16 | $9,872 | $2,149 | 21.8% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 26 | 31 | $60,450 | $1,914 | 3.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 23 | $12,788 | $1,910 | 14.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 66 | $43,362 | $1,799 | 4.1% |
| 43247 | Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 18 | $12,346 | $1,637 | 13.3% |
| 43277 | Balloon dilation of pancreatic or bile duct or sphincter using a flexible endoscope | Facility | 2023 | 13 | 15 | $15,390 | $1,582 | 10.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $19,780 | $998.69 | 5.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 37 | 47 | $58,797 | $13,001 | 22.1% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 41 | 43 | $53,427 | $7,477 | 14.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 21 | 23 | $27,002 | $3,849 | 14.3% |
| 43266 | Placement of stent in esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 26 | $16,042 | $3,305 | 20.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $9,022 | $3,284 | 36.4% |
| 43247 | Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 28 | 37 | $26,797 | $3,156 | 11.8% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2022 | 25 | 25 | $15,025 | $3,098 | 20.6% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 13 | 13 | $10,730 | $2,842 | 26.5% |
About Dr. Ashish Sharma, MD
Dr. Ashish Sharma, MD is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003992736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Sharma, MD has received a total of $3,786 in payments from pharmaceutical and medical device companies, with $381.77 received in 2024. These payments were reported across 217 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,975).
As a Medicare-enrolled provider, Sharma has provided services to 1,925 Medicare beneficiaries, totaling 2,300 services with total Medicare billing of $242,348. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Wayne, IN
- Active Since 10/27/2006
- Last Updated 09/30/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1003992736
Products in Payments
- LINZESS (Drug) $783.04
- ZENPEP (Drug) $333.27
- ENTYVIO (Biological) $164.56
- XIFAXAN (Drug) $159.45
- CREON (Drug) $139.56
- GI GENIUS (Device) $138.16
- Braftovi (Drug) $136.37
- HUMIRA (Biological) $109.47
- DIFICID (Drug) $104.19
- EndoFlip (Device) $68.84
- Humira (Biological) $63.74
- VIBERZI (Drug) $46.48
- TRULANCE (Drug) $44.69
- ZEPOSIA (Drug) $43.12
- DUPIXENT (Biological) $42.31
- GATTEX (Drug) $36.89
- REMICADE (Biological) $35.01
- STELARA (Biological) $28.05
- OMVOH (Drug) $25.41
- SKYRIZI (Biological) $23.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732